Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients (2019)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.1007/s00406-018-0905-3
- Subjects: DOENÇA DE ALZHEIMER; BIOMARCADORES; LEUCÓCITOS; PROTEÍNAS DA MEMBRANA; PLAQUETAS SANGUÍNEAS; ENZIMAS PROTEOLÍTICAS; GLICOPROTEÍNAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2019
- Source:
- Título do periódico: European archives of psychiatry and clinical neuroscience
- ISSN: 0940-1334
- Volume/Número/Paginação/Ano: v. 269, n. 8, p. 963-972, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BRAM, Jessyka Maria de Franca et al. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, v. 269, n. 8, p. 963-972, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00406-018-0905-3. Acesso em: 03 jun. 2024. -
APA
Bram, J. M. de F., Talib, L. L., Joaquim, H. P. G., Sarno, T. A., Gattaz, W. F., & Forlenza, O. V. (2019). Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, 269( 8), 963-972. doi:10.1007/s00406-018-0905-3 -
NLM
Bram JM de F, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2019 ; 269( 8): 963-972.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s00406-018-0905-3 -
Vancouver
Bram JM de F, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2019 ; 269( 8): 963-972.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s00406-018-0905-3 - Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
- Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients
- Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons
- Inhibition of phospholipase A2 increases Tau phosphorylation at Ser214 in embryonic rat hippocampal neurons
- Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease
- Diagnosis and biomarkers of predementia in Alzheimer’s disease
Informações sobre o DOI: 10.1007/s00406-018-0905-3 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
